💉Pfizer's Moonshot, Lyft & Carbacid's Bubbles.
Pfizer released results, Lyft was on the rise and Kenya's Carbacid has bubbles fizzing from beneath the bottle.
Hey, Hisa fan,
It’s midweek, time to review your trading strategy, check on your profits and losses. Companies from both the local and global markets have been releasing financials, most of which are upbeat, giving investors sky-rocket returns.
Pfizer’s Moonshot.
Pfizer Inc [NYSE: PFE], the first company to receive full approval from the U.S Food and Drug Authority (FDA) approval, released impressive earnings on Tuesday after the market closed.
Pfizer’s financials showed a company that has made a killing out of the pandemic and it now stands out as one of the best in-return pharma companies listed across the globe.
Adjusted earnings were up 133% to $7.7 billion, from a year earlier.
Revenue soared 134% to $24.1 billion.
vaccine revenue rose to $14.6 billion from only $1.7 billion the company posted over a similar period last year.
Adjusted EPS rose 129% compared to the year-ago quarter, surpassing expectations by a wide margin.
Pfizer in the full-year earnings guidance said expects revenue for FY2021 between $81 billion to $82 billion a growth of $2 billion from its earlier guidance.
Commentary
Pfizer’s shares were up 4% during after-hours trading on Tuesday at $45.45 per share and are expected to maintain an upward trajectory until when the full-year results are released. Pfizer’s results could provide an extra clue to other Pharma companies due to release their financials this week with a greater highlight on Moderna Inc who’s results are due on Thursday.
Pfizer had on Friday last week received emergency approval from the FDA to provide their vaccine to children between the ages of 5 to 11.
Lifting Off the Weight.
Lyft Inc, [NASDAQ: LYFT] the corporate rival to giant ride-hailing app Uber, said on Tuesday that their drivers were coming back despite missing analysts estimates.
Earnings per share for the quarter was at $0.05 adjusted vs a loss per share of $0.03 per share polled by analysts.
Lyft posted a net loss for the quarter of $71.5 million compared with a net loss of $459.5 million posted over the same period of 2020.
Revenue grew 13% quarter-over-quarter to $864.4 million.
Revenue per active rider was up 14% year-on-year to $45.63.
Active riders in the hailing app missed analysts expectations at 18.9 million compared to the 19.7 million expected by analysts.
Lyft’s shares jumped 12% in after-hours trading to $51.51 per share and have already gained a total of 14.30% in pre-market trading after the company’s CEO Logan Green provided a fourth-quarter outlook, telling investors it expects revenue between $930 million and $940 million.
Carbacid [NSE: CARB]
East Africa's largest producer of natural, food-grade, compressed carbon dioxide Carbacid Plc released its full-year earnings early Tuesday.
Carbacid posted a 28% jump in net income to Kes 415 million vs 324 million posted in FY2019/2020.
Turnover for the full year posted a 33% jump at Kes 906.6 million.
Unrealized gains from holdings in listed companies jumped to Kes 12 million from the loss of 38 million posted in 2020.
Earnings per share for the year gained to Kes 1.63 per share from 1.27 per share.
Carbacid announced a final dividend of Kes 0.70 per share.
Shares of carbacid rallied but stabilized about 4.24% during Tuesday’s trading, an activity it extended into Wednesday with a 6.91% jump after investors noted the comany’’s special surprise of a Kes 0.90 per share special dividend.
Earnings Calendar.
Disclaimer:Â This newsletter does not constitute investment recommendations. Investors and the general public are advised to do their own research before making any investment decision.